COMP <GO>
SIGA vs ABBV // NET PROFIT MARGIN
SIGA Technologies Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: SIGA 7
— ABBV 6
▲ NET PROFIT MARGIN LEADER: SIGA
LAST: $3.04 (-4.40%) • MKT CAP: $228.5M
net-margins
24.60%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
net-margins
6.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIGA VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SIGA | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.60% | 70.20% | -1.60 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 42.70% | 29.00% | +13.70 | SIGA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.8x | 33.3x | -28.50 | SIGA | /valuation <GO> |
| Free Cash Flow Yield | 19.03% | 3.47% | +15.56 | SIGA | /fcf-yield <GO> |
| Operating Margin | 25.10% | 24.60% | +0.50 | SIGA | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 24.60% | 6.90% | +17.70 | SIGA | /net-margins <GO> |
| Revenue Growth (YoY) | -31.80% | 8.60% | -40.40 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.22 | 5.33 | +2.89 | SIGA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.7 | 65.1 | -28.41 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.1x | 113.1x | -104.00 | SIGA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $228.5M | $513.86B | -$513.63B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SIGA REV | ABBV REV | SIGA GROSS % | ABBV GROSS % | SIGA FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $94.6M | $61.16B | 68.6% | 70.2% | $43.5M | $17.82B |
| FY 2024 | $138.7M | $56.33B | 77.4% | 70.0% | $48.8M | $17.83B |
| FY 2023 | $139.9M | $54.32B | — | — | $94.8M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIGA // BETA —
ABBV // BETA 1.15